Rovin, Brad H.

Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression

Chen, X.-L., Dodd, G., Thomas, S., Zhang, X., Wasserman, M. A., Rovin, B. H., & Kunsch, C. (2006) · American Journal of Physiology-Heart and Circulatory Physiology

Genomics, phytochemicals, and oxidative stressNitric Oxide and Endothelin Effects

Cited by 418

Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus nephritis cohort

Dall'Era, M., Cisternas, M. G., Smilek, D. E., Straub, L., Houssiau, F. A., Cervera, R., Rovin, B. H., & Mackay, M. (2015) · Arthritis & Rheumatology

Systemic Lupus Erythematosus ResearchRenal Diseases and Glomerulopathies

Cited by 329

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Floege, J., Barbour, S. J., Cattran, D. C., Hogan, J. J., Nachman, P. H., Tang, S. C. W., Wetzels, J. F. M., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 263

Management of Glomerular Proteinuria: A Commentary

Wilmer, W. A., Rovin, B. H., Hebert, C. J., Rao, S. V., Kumor, K., & Hebert, L. A. (2003) · Journal of the American Society of Nephrology

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 217

KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)

Rovin, B. H., Barratt, J., Cook, H. T., Noronha, I. L., Reich, H. N., Suzuki, Y., Tang, S. C. W., Trimarch, H., & Floege, J. (2025) · Kidney International

Renal Diseases and GlomerulopathiesVasculitis and related conditions

Cited by 206

Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis

Gomez Mendez, L. M., Cascino, M. D., Garg, J., Katsumoto, T. R., Brakeman, P., Dall’Era, M., Looney, R. J., Rovin, B., Dragone, L., & Brunetta, P. (2018) · Clinical Journal of the American Society of Nephrology

Systemic Lupus Erythematosus ResearchRenal Diseases and Glomerulopathies

Cited by 188

Biomarkers of lupus nephritis determined by serial urine proteomics

Zhang, X., Jin, M., Wu, H., Nadasdy, T., Nadasdy, G., Harris, N., Green-Church, K., Nagaraja, H., Birmingham, D. J., Yu, C.-Y., et al. (2008) · Kidney International

Systemic Lupus Erythematosus ResearchRenal Diseases and Glomerulopathies

Cited by 136

APOE Kyoto Mutation in European Americans with Lipoprotein Glomerulopathy

Rovin, B. H., Roncone, D., McKinley, A., Nadasdy, T., Korbet, S. M., & Schwartz, M. M. (2007) · New England Journal of Medicine

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 35

Iptacopan in IgA Nephropathy — Final 24-Month Data

Barratt, J., Eren, N., Kashihara, N., Maes, B., Rizk, D. V., Rovin, B., Trimarchi, H., Zhang, H., Wang, W., Kocyigit, I., et al. (2026) · New England Journal of Medicine

Renal Diseases and GlomerulopathiesComplement system in diseases

Cited by 34

A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy

Bomback, A. S., Song, H., D'Agati, V. D., Cohen, S. D., Neal, A., Appel, G. B., & Rovin, B. H. (2010) · Nephrology Dialysis Transplantation

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 25

Individualised treatment effects of corticosteroids in IgA nephropathy

Hölscher, D. L., Schmitz, N. E. J., Niggemeier, L., Pilva, P., Strauch, M., Tesar, V., Barratt, J., Roberts, I. S. D., Coppo, R., Barisoni, L., et al. (2026) · eBioMedicine

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 2